Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trial von Motzer, Robert J, Dr, Hutson, Thomas E, DO, Glen, Hilary, MD, Michaelson, M Dror, MD, Molina, Ana, MD, Eisen, Timothy, Prof, Jassem, Jacek, Prof, Zolnierek, Jakub, MD, Maroto, Jose Pablo, MD, Mellado, Begoña, MD, Melichar, Bohuslav, Prof, Tomasek, Jiri, MD, Kremer, Alton, MD, Kim, Han-Joo, PhD, Wood, Karen, PhD, Dutcus, Corina, MD, Larkin, James, FRCP

Volltext

Axitinib versus sorafenib as second-line treatment for advanced renal cell carcinoma: overall survival analysis and updated results from a randomised phase 3 trial von Motzer, Robert J, Dr, Escudier, Bernard, MD, Tomczak, Piotr, MD, Hutson, Thomas E, DO, Michaelson, M Dror, MD, Negrier, Sylvie, Prof, Oudard, Stephane, Prof, Gore, Martin E, Prof, Tarazi, Jamal, MD, Hariharan, Subramanian, MD, Chen, Connie, PharmD, Rosbrook, Brad, MS, Kim, Sinil, MD, Rini, Brian I, MD

Volltext

Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial von Rini, Brian I, Dr, Escudier, Bernard, MD, Tomczak, Piotr, MD, Kaprin, Andrey, Prof, Szczylik, Cezary, MD, Hutson, Thomas E, DO, Michaelson, M Dror, MD, Gorbunova, Vera A, Prof, Gore, Martin E, Prof, Rusakov, Igor G, Prof, Negrier, Sylvie, Prof, Ou, Yen-Chuan, Prof, Castellano, Daniel, MD, Lim, Ho Yeong, Prof, Uemura, Hirotsugu, Prof, Tarazi, Jamal, MD, Cella, David, PhD, Chen, Connie, PharmD, Rosbrook, Brad, MS, Kim, Sinil, MD, Motzer, Robert J, MD

Volltext

Prognostic or predictive plasma cytokines and angiogenic factors for patients treated with pazopanib for metastatic renal-cell cancer: a retrospective analysis of phase 2 and phase... von Tran, Hai T, PharmD, Liu, Yuan, PhD, Zurita, Amado J, MD, Lin, Ying, PhD, Baker-Neblett, Katherine L, MBA, Martin, Anne-Marie, PhD, Figlin, Robert A, MD, Hutson, Thomas E, DO, Sternberg, Cora N, MD, Amado, Rafael G, MD, Pandite, Lini N, MD, Heymach, John V, Dr

Volltext

Clear cell adenocarcinoma arising in endometriosis of the rectovaginal septum von Goldberg, M I, Belinson, J L, Hutson, E D, Nordqvist, S R

Volltext

Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma von Choueiri, Toni K, Escudier, Bernard, Powles, Thomas, Mainwaring, Paul N, Rini, Brian I, Donskov, Frede, Hammers, Hans, Hutson, Thomas E, Lee, Jae-Lyun, Peltola, Katriina, Roth, Bruce J, Bjarnason, Georg A, Géczi, Lajos, Keam, Bhumsuk, Maroto, Pablo, Heng, Daniel Y.C, Schmidinger, Manuela, Kantoff, Philip W, Borgman-Hagey, Anne, Hessel, Colin, Scheffold, Christian, Schwab, Gisela M, Tannir, Nizar M, Motzer, Robert J

Volltext

Regional Myocardial Sympathetic Denervation Predicts the Risk of Sudden Cardiac Arrest in Ischemic Cardiomyopathy von Fallavollita, James A., MD, Heavey, Brendan M., MPH, Luisi, Andrew J., MD, Michalek, Suzanne M., MS, Baldwa, Sunil, MBBS, Mashtare, Terry L., PhD, Hutson, Alan D., PhD, deKemp, Robert A., PhD, Haka, Michael S., PhD, Sajjad, Munawwar, PhD, Cimato, Thomas R., MD, Curtis, Anne B., MD, Cain, Michael E., MD, Canty, John M., MD

Volltext

Confronting false discoveries in single-cell differential expression von Squair, Jordan W., Gautier, Matthieu, Kathe, Claudia, Anderson, Mark A., James, Nicholas D., Hutson, Thomas H., Hudelle, Rémi, Qaiser, Taha, Matson, Kaya J. E., Barraud, Quentin, Levine, Ariel J., La Manno, Gioele, Skinnider, Michael A., Courtine, Grégoire

Volltext

Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial von Choueiri, Toni K, Dr, Escudier, Bernard, MD, Powles, Thomas, Prof, Tannir, Nizar M, Prof, Mainwaring, Paul N, MD, Rini, Brian I, Prof, Hammers, Hans J, MD, Donskov, Frede, MD, Roth, Bruce J, Prof, Peltola, Katriina, MD, Lee, Jae Lyun, Prof, Heng, Daniel Y C, MD, Schmidinger, Manuela, Prof, Agarwal, Neeraj, MD, Sternberg, Cora N, Prof, McDermott, David F, MD, Aftab, Dana T, PhD, Hessel, Colin, MS, Scheffold, Christian, MD, Schwab, Gisela, MD, Hutson, Thomas E, Prof, Pal, Sumanta, MD, Motzer, Robert J, Prof

Volltext

Functional design for operational earth resources ground data processing von Baldwin, C. J., Bradford, L. H., Hutson, D. E., Jugle, D. R.

Volltext bestellen

Prognostic factors for progression-free and overall survival with sunitinib targeted therapy and with cytokine as first-line therapy in patients with metastatic renal cell carcinom... von Patil, S., Figlin, R.A., Hutson, T.E., Michaelson, M.D., Négrier, S., Kim, S.T., Huang, X., Motzer, R.J.

Volltext

Optimal adaptive two-stage designs for early phase II clinical trials von Shan, Guogen, Wilding, Gregory E., Hutson, Alan D., Gerstenberger, Shawn

Volltext

Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial von Motzer, Robert J, Dr, Prof, Escudier, Bernard, MD, Oudard, Stéphane, Prof, Hutson, Thomas E, Prof, Porta, Camillo, MD, Bracarda, Sergio, MD, Grünwald, Viktor, Prof, Thompson, John A, Prof, Figlin, Robert A, Prof, Hollaender, Norbert, PhD, Urbanowitz, Gladys, BS, Berg, William J, MD, Kay, Andrea, MD, Lebwohl, David, MD, Ravaud, Alain, Prof

Volltext

Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma von Motzer, Robert, Alekseev, Boris, Rha, Sun-Young, Porta, Camillo, Eto, Masatoshi, Powles, Thomas, Grünwald, Viktor, Hutson, Thomas E, Kopyltsov, Evgeny, Méndez-Vidal, María J, Kozlov, Vadim, Alyasova, Anna, Hong, Sung-Hoo, Kapoor, Anil, Alonso Gordoa, Teresa, Merchan, Jaime R, Winquist, Eric, Maroto, Pablo, Goh, Jeffrey C, Kim, Miso, Gurney, Howard, Patel, Vijay, Peer, Avivit, Procopio, Giuseppe, Takagi, Toshio, Melichar, Bohuslav, Rolland, Frederic, De Giorgi, Ugo, Wong, Shirley, Bedke, Jens, Schmidinger, Manuela, Dutcus, Corina E, Smith, Alan D, Dutta, Lea, Mody, Kalgi, Perini, Rodolfo F, Xing, Dongyuan, Choueiri, Toni K

Volltext

Everolimus in metastatic renal cell carcinoma: Subgroup analysis of patients with 1 or 2 previous vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapies en... von Calvo, E, Escudier, B, Motzer, R.J, Oudard, S, Hutson, T.E, Porta, C, Bracarda, S, Grünwald, V, Thompson, J.A, Ravaud, A, Kim, D, Panneerselvam, A, Anak, O, Figlin, R.A

Volltext

Axitinib versus sorafenib as first-line therapy in patients with metastatic renal-cell carcinoma: a randomised open-label phase 3 trial von Hutson, Thomas E, Prof, Lesovoy, Vladimir, Prof, Al-Shukri, Salman, Prof, Stus, Viktor P, Prof, Lipatov, Oleg N, Prof, Bair, Angel H, PhD, Rosbrook, Brad, MS, Chen, Connie, PharmD, Kim, Sinil, MD, Vogelzang, Nicholas J, Prof

Volltext

Relationships between pazopanib exposure and clinical safety and efficacy in patients with advanced renal cell carcinoma von Suttle, A B, Ball, H A, Molimard, M, Hutson, T E, Carpenter, C, Rajagopalan, D, Lin, Y, Swann, S, Amado, R, Pandite, L

Volltext

Design requirements for operational earth resources ground data processing von Baldwin, C. J., Bradford, L. H., Burnett, E. S., Hutson, D. E., Kinsler, B. A., Kugle, D. R., Webber, D. S.

Volltext bestellen

Dietary Supplement Use During Chemotherapy and Survival Outcomes of Patients With Breast Cancer Enrolled in a Cooperative Group Clinical Trial (SWOG S0221) von Ambrosone, Christine B, Zirpoli, Gary R, Hutson, Alan D, McCann, William E, McCann, Susan E, Barlow, William E, Kelly, Kara M, Cannioto, Rikki, Sucheston-Campbell, Lara E, Hershman, Dawn L, Unger, Joseph M, Moore, Halle C F, Stewart, James A, Isaacs, Claudine, Hobday, Timothy J, Salim, Muhammad, Hortobagyi, Gabriel N, Gralow, Julie R, Budd, George T, Albain, Kathy S

Volltext

Phase 3 Trial of Everolimus for Metastatic Renal Cell Carcinoma: Final Results and Analysis of Prognostic Factors von MOTZER, Robert J, ESCUDIER, Bernard, KAY, Andrea, RAVAUD, Alain, OUDARD, Stephane, HUTSON, Thomas E, PORTA, Camillo, BRACARDA, Sergio, GRÜNWALD, Viktor, THOMPSON, John A, FIGLIN, Robert A, HOLLAENDER, Norbert

Volltext